Research ArticleOriginal Article
Open Access

Predictive value of ferritin, glucose, urea, and creatinine for COVID-19 severity and mortality in patients from Asir, Saudi Arabia

Ahmad A. Shaikh, Turki A. Mubasher, Mohammed H. Makkawi and Sultan Z. Alasmari
Saudi Medical Journal August 2023, 44 (8) 773-781; DOI: https://doi.org/10.15537/smj.2023.44.8.20230162

References

  1. 1.↵
    1. Rabi FA,
    2. Al Zoubi MS,
    3. Kasasbeh GA,
    4. Salameh DM,
    5. Al-Nasser AD.
    SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens 2020; 9: 231.
    OpenUrlPubMed
  2. 2.↵
    1. Velavan TP,
    2. Meyer CG.
    The COVID-19 epidemic. Trop Med Int Health 2020; 25: 278–280.
    OpenUrlCrossRefPubMed
  3. 3.↵
    World Health Organization. Coronavirus disease (COVID-2019) Dashboard. Updated 2023; Accessed 2023 May 30]. Available from: https://www.who.int/
  4. 4.↵
    Ministry of Health and Saudi Arabia. Covid 19 dashboard: Saudi Arabia. [Updated 2022; Accessed 2023 May 30]. Available from: https://covid19.moh.gov.sa
  5. 5.↵
    1. Zhao J,
    2. Yang Y,
    3. Huang H,
    4. Li D,
    5. Gu D,
    6. Lu X, et al.
    Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis 2021; 73: 328–331.
    OpenUrlPubMed
  6. 6.↵
    1. Ad’hiah AH,
    2. Allami RH,
    3. Mohsin RH,
    4. Abdullah MH
    , AL-Sa’ady AJR, Alsudani MY. Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients. Egypt J Med Hum Genet 2020; 21: 1–6.
    OpenUrl
  7. 7.↵
    1. Zheng Z,
    2. Peng F,
    3. Xu B,
    4. Zhao J,
    5. Liu H,
    6. Peng J, et al.
    Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect 2020; 81: e16–e25.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z, et al.
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y, et al.
    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Zhang JJ,
    2. Cao YY,
    3. Tan G,
    4. Dong X,
    5. Wang BC,
    6. Lin J, et al.
    Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy 2021; 76: 533–550.
    OpenUrlPubMed
  11. 11.↵
    1. Weiss P,
    2. Murdoch DR.
    Clinical course and mortality risk of severe COVID-19. Lancet 2020; 395: 1014–1015.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. El-Kady AM,
    2. Aldakheel FM,
    3. Allemailem KS,
    4. Almatroudi A,
    5. Dbas Alharbi R,
    6. Al Hamed H, et al.
    Clinical characteristics, outcomes and prognostic factors for critical illness in hospitalized COVID-19 patients in Saudi Arabia: a retrospective cohort study. Int J Gen Med 2022; 15: 6945–6963.
    OpenUrl
  13. 13.↵
    1. Badedi M,
    2. Alnami A,
    3. Darraj H,
    4. Alrajhi A,
    5. Mutawwam DA,
    6. Somaily M, et al.
    Clinical characteristics and ABO blood groups in COVID-19 patients, Saudi Arabia. Medicine (Baltimore) 2021; 100: e26738.
    OpenUrl
  14. 14.↵
    1. Romero Starke K,
    2. Petereit-Haack G,
    3. Schubert M,
    4. Kämpf D,
    5. Schliebner A,
    6. Hegewald J, et al.
    The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression. Int J Environ Res Public Health 2020; 17: 5974.
    OpenUrlPubMed
  15. 15.↵
    1. Bajaj V,
    2. Gadi N,
    3. Spihlman AP,
    4. Wu SC,
    5. Choi CH,
    6. Moulton VR. Aging
    , immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front Physiol 2021; 11: 571416.
    OpenUrl
  16. 16.↵
    1. Pan A,
    2. Liu L,
    3. Wang C,
    4. Guo H,
    5. Hao X,
    6. Wang Q, et al.
    Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA 2020; 323: 1915–1923.
    OpenUrlPubMed
  17. 17.↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J, et al.
    Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Abolfotouh MA,
    2. Musattat A,
    3. Alanazi M,
    4. Alghnam S,
    5. Bosaeed M.
    Clinical characteristics and outcome of COVID-19 illness and predictors of in-hospital mortality in Saudi Arabia. BMC Infect Dis 2022; 22: 950.
    OpenUrl
  19. 19.↵
    1. Alharbi AA,
    2. Alqassim AY,
    3. Gosadi IM,
    4. Aqeeli AA,
    5. Muaddi MA,
    6. Makeen AM, et al.
    Regional differences in COVID-19 ICU admission rates in the Kingdom of Saudi Arabia: a simulation of the new model of care under vision 2030. J Infect Public Health 2021; 14: 717–723.
    OpenUrl
  20. 20.↵
    1. Yaylacı S,
    2. Dheir H,
    3. İşsever K,
    4. Genc AB,
    5. Şenocak D,
    6. Kocayigit H, et al.
    The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Rev Assoc Med Bras (1992) 2020; 66: 86–90.
    OpenUrl
  21. 21.
    1. Alacam S,
    2. Sari ND.
    Could the ABO blood group types be associated with COVID-19 mortality? Med Bull Haseki 2021; 59: 345–349.
  22. 22.
    1. Valenti L,
    2. Villa S,
    3. Baselli G,
    4. Temporiti R,
    5. Bandera A,
    6. Scudeller L, et al.
    Association of ABO blood group and secretor phenotype with severe COVID-19. Transfusion 2020; 60: 3067–3070.
    OpenUrl
  23. 23.↵
    1. Deleers M,
    2. Breiman A,
    3. Daubie V,
    4. Maggetto C,
    5. Barreau I,
    6. Besse T, et al.
    COVID-19 and blood groups: ABO antibody levels may also matter. Int J Infect Dis 2021; 104: 242–249.
    OpenUrl
  24. 24.↵
    1. Zietz M,
    2. Zucker J,
    3. Tatonetti NP.
    Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun 2020; 11: 5761.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Nalbant A,
    2. Aydın A,
    3. Yaylacı S,
    4. Kaya T,
    5. Wermeulen CL,
    6. Cinemre H.
    Association of ABO blood group and age with COVID-19 positive test. Rev Assoc Med Bras (1992) 2021; 67: 46–50.
    OpenUrl
  26. 26.↵
    1. Nasif WA,
    2. Ali ASE,
    3. Khogeer AA,
    4. Mukhtar MH,
    5. NourEldein MM,
    6. Shebly AY, et al.
    Emphasizing the link between blood types in multi-ethnic disparities and COVID-19 infection in Makkah, Saudi Arabia. Saudi Med J 2022; 43: 177–186.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Belali TM.
    Distribution of ABO and rhesus types in the Northern Asir Region in Saudi Arabia. J Blood Med 2022; 13: 643–648.
    OpenUrl
  28. 28.↵
    1. Wu Y,
    2. Feng Z,
    3. Li P,
    4. Yu Q.
    Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta 2020; 509: 220–223.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Goel R,
    2. Bloch EM,
    3. Pirenne F,
    4. Al-Riyami AZ,
    5. Crowe E,
    6. Dau L, et al.
    ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group. Vox Sang 2021; 116: 849–861.
    OpenUrlPubMed
  30. 30.↵
    1. Bendardaf R,
    2. Bhamidimarri PM,
    3. Al-Abadla Z,
    4. Zein D,
    5. Alkhayal N,
    6. Georgy RR, et al.
    Ferritin, blood urea nitrogen, and high chest CT score determines ICU admission in COVID-19 positive UAE patients: a single center retrospective study. PLoS One 2022; 17: e0269185.
    OpenUrl
  31. 31.↵
    1. Asghar MS,
    2. Ahsan MN,
    3. Akram M,
    4. Hassan M,
    5. Rasheed U,
    6. Adnan SM.
    Frequency of deranged renal profile in patients with COVID-19: tertiary care experience from a developing country. Saudi J Kidney Dis Transpl 2021; 32: 377–386.
    OpenUrl
  32. 32.↵
    1. Devang N,
    2. Sreelatha S,
    3. Mamatha BV.
    Assessment of inflammatory markers and their association with disease mortality in severe COVID-19 patients of tertiary care hospital in south india. Egypt J Bronchol 2022; 16: 1–7.
    OpenUrl
  33. 33.
    1. Ramos Rojas MC,
    2. Cuaresma Cuadros EA,
    3. Cayo Castillo JJ,
    4. Monasterio Benique DA.
    Association of biomarkers and severity of COVID-19: a crosssectional study. Medwave 2022; 22: e002548.
    OpenUrl
  34. 34.↵
    1. Wang W,
    2. Shen M,
    3. Tao Y,
    4. Fairley CK,
    5. Zhong Q,
    6. Li Z, et al.
    Elevated glucose level leads to rapid COVID-19 progression and high fatality. BMC Pulm Med 2021; 21: 64.
    OpenUrl
  35. 35.↵
    1. Wadke R,
    2. Singh S,
    3. Gupta A,
    4. Samel S,
    5. Taank P.
    Correlation of inflammatory markers with renal dysfunction and their outcome in symptomatic adult COVID-19 patients. J Med Sci 2022; 42: 127–133.
    OpenUrl
  36. 36.↵
    1. Kaushal K,
    2. Kaur H,
    3. Sarma P,
    4. Bhattacharyya A,
    5. Sharma DJ,
    6. Prajapat M, et al.
    Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care 2022; 67: 172–181.
    OpenUrl
  37. 37.↵
    1. Wu C,
    2. Chen X,
    3. Cai Y,
    4. Xia J,
    5. Zhou X,
    6. Xu S, et al.
    Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 934–943.
    OpenUrl
  38. 38.↵
    1. Temiz MZ,
    2. Hacibey I,
    3. Yazar RO,
    4. Sevdi MS,
    5. Kucuk SH,
    6. Alkurt G, et al.
    Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Ren Fail 2022; 44: 233–240.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords